The effects of asthma medications on reactive oxygen species production in human monocytes

References

• Jiang L, Diaz PT, Best TM, Stimpfl JN, He F, Zuo L. Molecular characterization of redox mechanisms in allergic asthma. Ann Allergy Asthma Immunol 2014;113(2):137–142.
   PubMed Web of Science ®Google Scholar
• Zuo L, Otenbaker NP, Rose BA, Salisbury KS. Molecular mechanisms of reactive oxygen species-related pulmonary inflammation and asthma. Mol Immunol 2013;56(1–2):57–63.
   PubMed Web of Science ®Google Scholar
• Qu J, Li Y, Zhong W, Gao P, Hu C. Recent developments in the role of reactive oxygen species in allergic asthma. J Thoracic Dis 2017;9(1):E32–e43.
   PubMed Web of Science ®Google Scholar
• Delfino RJ, Staimer N, Tjoa T, Gillen DL, Schauer JJ, Shafer MM. Airway inflammation and oxidative potential of air pollutant particles in a pediatric asthma panel. J Exposure Sci Environ Epidemiol 2013;23(5):466–473.
   PubMed Web of Science ®Google Scholar
• Hung CH, Li CY, Lai YS, Hsu PC, Hua YM, Yang KD. Discrepant clinical responses and blood chemokine profiles between two non-steroidal anti-inflammatory medications for children with mild persistent asthma. Pediatr Allergy Immunol 2005;16(4):306–309.
   PubMed Web of Science ®Google Scholar
• Woszczek G, Chen LY, Alsaaty S, Nagineni S, Shelhamer JH. Concentration-dependent noncysteinyl leukotriene type 1 receptor-mediated inhibitory activity of leukotriene receptor antagonists. J Immunol (Baltimore, Md: 1950). 2010;184(4):2219–2225.
   Google Scholar
• Tachibana A, Kato M, Kimura H, Fujiu T, Suzuki M, Morikawa A. Inhibition by fenoterol of human eosinophil functions including beta2-adrenoceptor-independent actions. Clin Exp Immunol 2002;130(3):415–423.
   PubMed Web of Science ®Google Scholar
• Anderson R, Feldman C, Theron AJ, Ramafi G, Cole PJ, Wilson R. Anti-inflammatory, membrane-stabilizing interactions of salmeterol with human neutrophils in vitro. Br J Pharmacol 1996;117(7):1387–1394.
   PubMed Web of Science ®Google Scholar
• Shinkai N, Takasuna K, Takayama S. Inhibitory effects of formoterol on lipopolysaccharide-induced premature delivery through modulation of proinflammatory cytokine production in mice. Reproduction (Cambridge, England) 2003;125(2):199–203.
   PubMed Web of Science ®Google Scholar
• Sekut L, Champion BR, Page K, Menius JA, Jr., Connolly KM. Anti-inflammatory activity of salmeterol: down-regulation of cytokine production. Clin Exp Immunol 1995;99(3):461–466.
   PubMed Web of Science ®Google Scholar
• Bissonnette EY, Befus AD. Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells. J Allergy Clin Immunol 1997;100(6 Pt 1):825–831.
   PubMed Web of Science ®Google Scholar
• Cazzola M, Proietto A, Matera MG. Indacaterol for chronic obstructive pulmonary disease (COPD). Drugs Today (Barcelona, Spain: 1998) 2010;46(3):139–150.
   Google Scholar
• Pelaia G, Maselli R, Matera MG. Treatment of chronic obstructive pulmonary disease by dual bronchodilation with coformulation of indacaterol/glycopyrronium. Pharmacology 2014;94(5–6):249–258.
   PubMed Web of Science ®Google Scholar
• Alangari AA, Malhis N, Mubasher M, Al-Ghamedi N, Al-Tannir M, Riaz M, et al. Budesonide nebulization added to systemic prednisolone in the treatment of acute asthma in children: a double-blind, randomized, controlled trial. Chest 2014;145(4):772–778.
   PubMed Web of Science ®Google Scholar
• Khanduja KL, Kaushik G, Khanduja S, Pathak CM, Laldinpuii J, Behera D. Corticosteroids affect nitric oxide generation, total free radicals production, and nitric oxide synthase activity in monocytes of asthmatic patients. Mol Cell Biochem 2011;346(1–2):31–37.
   PubMed Web of Science ®Google Scholar
• Chanput W, Mes JJ, Wichers HJ. THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol 2014;23(1):37–45.
   PubMed Web of Science ®Google Scholar
• Sanchez-Sanchez AM, Martin V, Garcia-Santos G, Rodriguez-Blanco J, Casado-Zapico S, Suarez-Garnacho S, et al. Intracellular redox state as determinant for melatonin antiproliferative vs cytotoxic effects in cancer cells. Free Rad Res 2011;45(11–12):1333–1341.
   PubMed Web of Science ®Google Scholar
• Zhao XY, Li GY, Liu Y, Chai LM, Chen JX, Zhang Y, et al. Resveratrol protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Br J Pharmacol 2008;154(1):105–113.
   PubMed Web of Science ®Google Scholar
• Korn SH, Jerre A, Brattsand R. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J 2001;17(6):1070–1077.
   PubMed Web of Science ®Google Scholar
• Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999;399(6738):789–793.
   PubMed Web of Science ®Google Scholar
• Jaffer OA, Carter AB, Sanders PN, Dibbern ME, Winters CJ, Murthy S, et al. Mitochondrial-targeted antioxidant therapy decreases transforming growth factor-beta-mediated collagen production in a murine asthma model. Am J Respir Cell Mol Biol 2015;52(1):106–115.
   PubMed Web of Science ®Google Scholar
• Szefler SJ, Carlsson LG, Uryniak T, Baker JW. Budesonide inhalation suspension versus montelukast in children aged 2 to 4 sources with mild persistent asthma. J Allergy Clin Immunol Pract 2013;1(1):58–64.
   PubMed Web of Science ®Google Scholar
• Ravasi S, Citro S, Viviani B, Capra V, Rovati GE. CysLT1 receptor-induced human airway smooth muscle cells proliferation requires ROS generation, EGF receptor transactivation and ERK1/2 phosphorylation. Respir Res 2006;7:42.
   PubMed Web of Science ®Google Scholar
• Shah MB, Gohil J, Khapekar S, Dave J. Montelukast versus budesonide as a first line preventive therapy in mild persistent asthma in 2 to 18 y. Indian J Pediatr 2014;81(7):655–659.
   PubMed Web of Science ®Google Scholar
• Bisgaard H. Effect of long-acting beta2 agonists on exacerbation rates of asthma in children. Pediatr Pulmonol 2003;36(5):391–398.
   PubMed Web of Science ®Google Scholar
• Lombardi D, Cuenoud B, Kramer SD. Lipid membrane interactions of indacaterol and salmeterol: do they influence their pharmacological properties? Eur J Pharmaceut Sci 2009;38(5):533–547.
   PubMed Web of Science ®Google Scholar
• Bisgaard H. Long-acting beta(2)-agonists in management of childhood asthma: A critical review of the literature. Pediatr Pulmonol 2000;29(3):221–234.
   PubMed Web of Science ®Google Scholar
• Aaronson DW. The “black box” warning and allergy drugs. J Allergy Clin Immunol 2006;117(1):40–44.
   PubMed Web of Science ®Google Scholar
• Bartemes KR, McKinney S, Gleich GJ, Kita H. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. J Immunol (Baltimore, Md: 1950) 1999;162(5):2982–2989.
   Google Scholar
• Barnes PJ. Reactive oxygen species and airway inflammation. Free Rad Biol Med 1990;9(3):235–243.
   PubMed Web of Science ®Google Scholar